Blog
RSS FeedPosted by Michael Wonder on 18 May 2020
The coronavirus exposed the US' reliance on India for generic drugs. But that supply chain is ultimately controlled by China
17 May 2020 - Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to ...
Posted by Michael Wonder on 14 May 2020
Emergency use authorisation of remdesivir: the need for a transparent distribution process
14 May 2020 - On 4 February 2020, the Secretary of the US Department of Health and Human Services (DHHS) determined ...
Posted by Michael Wonder on 13 May 2020
Gilead strikes deal to make remdesivir coronavirus treatment in 127 countries
12 May 2020 - Gilead Sciences has struck a licensing agreement with five generic drugmakers to make anti-viral drug remdesivir in ...
Posted by Michael Wonder on 12 May 2020
Doctors face 'nearly an impossible situation' as they ration remdesivir
11 May 2020 - As coronavirus cases surged across the United States earlier this year, doctors faced a harrowing prospect. ...
Posted by Michael Wonder on 08 May 2020
Health care leaders question how remdesivir is being distributed
8 May 2020 - Hospitals and doctors seek more transparency on what criteria the Trump administration is using to ship the ...
Posted by Michael Wonder on 21 Apr 2020
DOJ clears U.S. drug companies to distribute hydroxychloroquine to coronavirus patients
21 April 2020 - The U.S. Department of Justice on Monday cited "extreme urgency" in clearing U.S. pharmaceutical distributors from ...
Posted by Michael Wonder on 15 Apr 2020
Novo Nordisk offers free 90 day insulin supply to people experiencing financial hardship due to COVID-19
14 April 2020 - People with diabetes using Novo Nordisk insulin who have lost health insurance coverage because of a ...
Posted by Michael Wonder on 15 Apr 2020
FEMA ships out nearly 20 million hydroxychloroquine tablets
14 April 2020 - A spokesperson for the agency confirmed that it has sent out 19.1 million tablets, including to Pittsburgh, ...
Posted by Michael Wonder on 07 Apr 2020
India again allows export of anti-malarial drug touted for coronavirus
7 April 2020 - President Trump had urged the country, one of hydroxychloroquine’s biggest producers, to release supplies of the medicine. ...
Posted by Michael Wonder on 06 Apr 2020
States try reducing malaria drug hoarding amid unproven coronavirus benefit
5 April 2020 - Limits on filling prescriptions for hydroxychloroquine are aimed at preserving supplies for lupus, arthritis patients. ...
Posted by Michael Wonder on 06 Apr 2020
India has cut off half the supply of a potential coronavirus treatment touted by Trump
6 April 2020 - Nearly half the supply of hydroxychloroquine to the U.S. comes from makers in India, a flow ...
Posted by Michael Wonder on 30 Mar 2020
Trump administration in talks with India to avoid U.S. drug supply shortage
31 March 2020 - India, the top source of generic drugs and ingredients, has restricted exports but the U.S. wants exemptions ...
Posted by Michael Wonder on 30 Mar 2020
Johnson & Johnson announces a lead vaccine candidate for COVID-19; landmark new partnership with U.S. Department of Health & Human Services; and commitment to supply one billion vaccines worldwide for emergency pandemic use
30 March 2020 - Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020. ...
Posted by Michael Wonder on 24 Mar 2020
As Trump touts an unproven coronavirus treatment, supplies evaporate for patients who need those drugs
24 March 2020 - The U.S. has all but exhausted its supplies of two anti-malarial drugs that are being used ...
Posted by Michael Wonder on 24 Mar 2020
Updates from Lilly about insulin supply and affordability
24 March 2020 - To keep the diabetes community informed about important developments from the COVID-19 crisis, Eli Lilly today is ...